Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by porksnifferon Sep 29, 2020 10:23am

80 Views

Post# 31634611

RE:Insiders are buying

wagyusteak wrote: Check it out:

Not much, but they haven't sold a share since inception. Haha

Those are NOT insider buys in the open market. LOL Those are employee plans with shares printed from treasury with discounts to market price. Stop spreading misinformation. NONE of these shares were bought in the open market using thier own cash. In the past year NO INSIDERS have purchased shares in the open market. This tells you all you need to know, even insiders are investing elsewhere LOLL. How much $$$$ are you losing???? Well into 6 year LOWS. S I X YEARS. Meir was bang on...LMAO

Bullboard Posts

Calibre discovers significant gold in Newfoundland